About HKTDC | Media Room | Contact HKTDC | Wish List Wish List () | My HKTDC |
繁體 简体
Save As PDF Print this page
Qzone

Heightened Oversight Mandated for Shenzhen Pharmaceutical Suppliers

Pharmaceutical suppliers active in and around Shenzhen are facing heightened supervision to ensure compliance with the Good Supply Practices for Pharmaceutical Products (GSP). These new arrangements have been mandated by the Shenzhen Food and Drug Administration and are in line with the prevailing requirements of the Drug Administration Law and other pertaining laws and regulations.

In all, three particular new requirements have been specified:

  • All pharmaceutical suppliers must comply with all GSP requirements
  • Should any inspection indicate that a company is trading in counterfeit or substandard pharmaceutical products, its GSP certification will be revoked in accordance with the relevant legislation or via the offices of the Guangdong Provincial Food and Drug Administration
  • Any company that continues to engage in the supply of pharmaceutical products after its GSP certification has been revoked (or after said certification has expired) will have its Pharmaceutical Trade Licence cancelled in accordance with the relevant legislation or via the offices of the presiding provincial food and drug administration

For further details (in Chinese), please visit the following link:

Circular of Shenzhen Food and Drug Administration on Strengthening Supervision of Drug Supply Enterprises after Issuance of Business Licence

Content provided by Picture: HKTDC Research
Comments (0)
Shows local time in Hong Kong (GMT+8 hours)

HKTDC welcomes your views. Please stay on topic and be respectful of other readers.
Review our Comment Policy

*Add a comment (up to 5,000 characters)